Publications 2011
Can't find the PDF you are looking for? Email Jessica Blodgett for assistance.
Publications: 2011
1 - Vultur, A., Villanueva, J, Herlyn, M.: Targeting BRAF in advanced melanoma: a first step towards manageable disease. Clin. Cancer Res., in 2011, March 29th (epub ahead of print). PMID 21447722 PDF
2 - Thurber, A.E., Douglas, G., Sturm, E.C., Zabierowksi, S. E., Smit, D.J., Ramakrishnan, S. N., Hacker, E., Leonard, J. H., Herlyn, M., Sturm, R.A. Inverse expression of BRN2 and MITF transcription factors in melanoma spheres and tumor xenografts regulate the NOTCH pathway. Oncogene. 2011. Feb 28 (epub ahead of print). PMID 21358674 PDF
3 - Magnitsky, S., Roesch, A., Herlyn, M., Glickson J.D.: In vivo and ex vivo MR imaging of slowly cycling melanoma cells. Magn. Reson. Med. April 26 (epub ahead of print). 2011. PMID 21523820 PDF
4 - Basu, D., Montone, K.T., Wang, L-P, Gimotty, P.A., Hammond, R., Diehl, J.A., Rustgi, A.K., Lee, J.T., Rasanen, K, Weinstein, G.S., Herlyn, M.: Detecting and targeting mesenchymal-like subpopulations within squamous cell carcinomas. Cell Cycle 10: 2008-20016, 2011. PMID 21558812.
5 - Li, L., Fukunaga-Kalabis, M., Herlyn, M.: The three-dimensional human skin reconstruct model: a tool to study normal skin and melanoma progression. J. Vis. Exp. Aug 3; 54.pli 2937. doi: 10.3791/2937. http://www.jove.com/details.php?id=2937&status=a4943k. PMID 21847077 PDF
6 - Zabierowski, S.E., Fukunaga-Kalabis, M., Li, L., Herlyn, M.: Dermis-derived stem cells: A source of epidermal melanocytes and melanoma? Pigment Cell Melanoma Res 24: 422-429, 2011. PMID 21410654 PDF
7 - Vultur, A., Villanueva, J., Herlyn, M.: Targeting BRAF in advanced melanoma: A first step towards manageable disease. Clin. Cancer Res.17: 1658-1663, 2011. PMID 21447722 PDF
8 - Fukunaga-Kalabis, M., Roesch, A., Herlyn, M.: From cancer stem cells to tumor maintainenance cells. J Invest. Dermatol 131: 1600-1604, 2011. PMID 21654838 PDF
9 - Zhang, G., Herlyn, M.: Tumor microenvironment for melanoma cells. In: Melanoma development. Molecular Biology, Genetics, and Clinical Application, ed. by A. Bosserhoff, Springer, WienNew York, pp. 297-308, 2011.
10 - Herlyn, M., Villanueva, J.: Sorting through the many opportunities for melanoma research. Pigm. Cell Melanoma Res. Sept. 8 [epub ahead of print], 2011. PMID 21899726 PDF
11 - Somasundaram, R., Villanueva, J., Herlyn, M.: Will engineered T cells expressing CD20 scFv eradicate melanoma? Molecular Therapy 19: 638-640, 2011. PMID 21455210 PDF
12 - Zabierowski, S.E., Baubet, V., Himes, B, Li, L., Fukunaga-Kalabis, M., Patel, S., McDaid, R., Guerra, M., Gimotty, P., Dahamne, N., and Herlyn, M.: Direct reprogramming of melanocytes to neural crest stem-like cells by one defined factor. Stem Cells, Nov. 29(11): 1752-62, 2011. PMID 21948558 PDF
13 - Ohashi, S., Natsuizaka, M., Naganuma, S., Kagawa, S., Kimura, S., Itoh, H., Kalman, R.A., Nakagawa, M., Darling, D.S., Basu, D., Gimotty, P.A., Klein-Szanto, A.J., Diehl, J.A., Herlyu, M., Nakagawa, Hi.: A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT competent cells that express the ZEB transcription factors. Cancer Res. Nov1;71(21):6636-6847, 2011. PMID 21890822 PDF
14 - Flach, E.H., Rebecca, V.W., Herlyn, M., Smalley, K.S.M., Anderson, A.R.A.: Fibroblasts contribute to melanoma tumor growth and drug resistance. Molecular Pharmaceutics. Dec 5; 8(6): 2039-49, 2011. PMID 22067046 PDF
15 - Blanck, S., Cruchter, T., Vultur, A., Riedel, R., Harms, K., Herlyn, M., Meggers, E.: Organometallic pyridylnaphtalamide complexes as protein kinase inhibitors. Organometallics 30: 4598-4606, 2011. PMID 21918590 PDF
16 - Villanueva, J., Vultur, A., Herlyn, M.: Resistance to BRAF inhibitors: Unraveling mechanisms and future treatment options. Cancer Res. Dec 1; 71(23); 7137-40, 2011. PMID 22131348 PDF
17 - Bogenrieder, T., and Herlyn, M.: The molecular pathology of cutaneous melanoma. Cancer Biomark 9: 267-286, 2011. PDF
